CinCor Pharma Inc.

NASDAQ: CINC · Real-Time Price · USD
29.06
0.00 (0.00%)
At close: Feb 23, 2023, 10:00 PM

CinCor Pharma Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
n/a n/a n/a n/a n/a n/a n/a
Gross Profit
n/a n/a n/a n/a n/a n/a n/a
Operating Income
-22.24M -21.35M -13.7M -25.23M -7.69M -5.17M -4.41M
Interest Income
1.27M 277.38K 51.45K 13.74K 1.95K 1.54K 4.41K
Pretax Income
-20.98M -21.08M -16.7M -29.34M -9.02M -6.38M -5.62M
Net Income
-19.71M -20.52M -19.64M -33.44M -9.02M -6.38M -5.62M
Selling & General & Admin
4.52M 4.19M 4.03M 13.85M 3.04M 1.18M 923.57K
Research & Development
17.73M 17.16M 9.67M 11.38M 4.65M 4M 3.49M
Other Expenses
n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
22.24M 21.35M 13.7M 25.23M 7.69M 5.17M 4.41M
Interest Expense
1.27M 277.38K 51.45K 13.74K 1.95K 1.54K 4.41K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
22.24M 21.35M 13.7M 25.23M 7.69M 5.17M 4.41M
Income Tax Expense
-1.27M -554.75K 2.94M 4.1M n/a n/a n/a
Shares Outstanding (Basic)
40.81M 37.71M 33.43M 35.42M 35.42M 34.36M 34.36M
Shares Outstanding (Diluted)
40.81M 37.71M 33.43M 35.42M 35.42M 34.36M 34.36M
EPS (Basic)
-0.48 -0.54 -0.59 -0.94 -0.25 -0.19 -0.16
EPS (Diluted)
-0.48 -0.54 -0.59 -0.94 -0.25 -0.19 -0.16
EBITDA
-22.24M -21.35M -13.7M -29.33M -9.02M -6.38M -5.61M
EBIT
-19.71M -20.8M -16.65M -29.33M -9.02M -6.38M -5.61M
Depreciation & Amortization
4.21K 86.06K 3.04M -4.1M -1.33M -1.21M -1.2M